Baxter International Financial Statements (BAX)

Baxter Internationalsmart-lab.ru %   2023Q1 2023Q2 2023Q3 2023Q4 2024Q1   LTM ?
Report date 27.04.2023 27.07.2023 02.11.2023 08.02.2024 02.05.2024   02.05.2024
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 3 649 3 707 3 708 3 885 3 592   14 892
Operating Income, bln rub -132.0 -17.0 -51.0 329.0 332.0   593.0
EBITDA, bln rub ? 187.0 302.0 -44.0 729.0 667.0   1 654
Net profit, bln rub ? 44.0 -141.0 2 508 245.0 37.0   2 649
OCF, bln rub ? 479.0 351.0 365.0 531.0 163.0   1 410
CAPEX, bln rub ? 172.0 156.0 174.0 190.0 176.0   696.0
FCF, bln rub ? 307.0 195.0 191.0 341.0 -13.0   714.0
Dividend payout, bln rub 146.0 146.0 147.0 147.0 147.0   587.0
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 331.8% 0.00% 5.86% 60.0% 397.3%   22.2%
OPEX, bln rub 1 161 1 129 1 168 1 107 1 016   4 420
Cost of production, bln rub 2 302 2 596 2 591 2 413 2 244   9 844
R&D, bln rub 164.0 165.0 166.0 172.0 160.0   663.0
Interest expenses, bln rub 117.0 132.0 128.0 117.0 103.0   480.0
Assets, bln rub 28 291 27 885 30 656 28 276 27 788   27 788
Net Assets, bln rub ? 5 879 5 569 8 101 8 402 8 173   8 173
Debt, bln rub 16 889 16 921 16 929 14 364 14 170   14 170
Cash, bln rub 1 673 1 722 5 788 3 194 3 026   3 026
Net debt, bln rub 15 216 15 199 11 141 11 170 11 144   11 144
Ordinary share price, rub 40.6 45.6 37.7 38.7 42.7   34.2
Number of ordinary shares, mln 505.0 506.0 507.0 507.0 508.0   508.0
Market cap, bln rub 20 483 23 053 19 134 19 601 21 712   17 374
EV, bln rub ? 35 699 38 252 30 275 30 771 32 856   28 518
Book value, bln rub -7 629 -7 319 -4 536 -4 191 -4 162   -4 162
EPS, rub ? 0.09 -0.28 4.95 0.48 0.07   5.21
FCF/share, rub 0.61 0.39 0.38 0.67 -0.03   1.41
BV/share, rub -15.1 -14.5 -8.95 -8.27 -8.19   -8.19
EBITDA margin, % ? 5.12% 8.15% -1.19% 18.8% 18.6%   11.1%
Net margin, % ? 1.21% -3.80% 67.6% 6.31% 1.03%   17.8%
FCF yield, % ? 3.76% 3.74% 4.87% 5.28% 3.29%   4.11%
ROE, % ? -41.8% -51.2% 32.0% 31.6% 32.4%   32.4%
ROA, % ? -8.68% -10.2% 8.46% 9.39% 9.53%   9.53%
P/E ? -8.34 -8.09 7.38 7.38 8.20   6.56
P/FCF 26.6 26.7 20.5 19.0 30.4   24.3
P/S ? 1.36 1.54 1.28 1.31 1.46   1.17
P/BV ? -2.68 -3.15 -4.22 -4.68 -5.22   -4.17
EV/EBITDA ? 23.2 34.1 37.2 26.2 19.9   17.2
Debt/EBITDA 9.88 13.5 13.7 9.51 6.74   6.74
R&D/CAPEX, % 95.3% 105.8% 95.4% 90.5% 90.9%   95.3%
CAPEX/Revenue, % 4.71% 4.21% 4.69% 4.89% 4.90%   4.67%
Baxter International shareholders